Les publications HAL IRSET

2023

564 publication(s):

Note: when necessary, only the first 5 authors are displayed.

Workshop/conference papers

: 521 -
: Non protective function of CXCL14 chemokine in acute viral hepatitis in coronavirus MHV infected mice and in human
: C. Devisme, Piquet C. Pellorce, A. Chalin, B. Lefevre, C. Pronier et al.
: Joint Conference of the Societe-Francaise-dImmunologie (SFI) and the Deutsche-Gesellschaft-fur-Immunologie (DGfI), Sep 2023, Strasbourg, France.

: 522 -
: A mixture of thymol and carvacrol mitigates inflammation and oxidative stress responses in intestinal epithelial cell models
: Delphine Gardan-Salmon, Arnaud Bruyère, Marisela Arturo-Schaan
: 71st International Congress and Annual Meeting of the Society-for-Medicinal-Plant-and-Natural-Product-Research, Jul 2023, Dublin, Ireland.
: DOI : https://doi.org/10.1055/s-0043-1774164

: 523 -
: Safety and quality of life analyses of apalutamide plus active surveillance vs active surveillance alone for low, intermediate risk prostate cancer.
: Gwenaelle Gravis, Patrick Sfumato, Guillaume Ploussard, Pierre-Henri Savoie, Matthieu Durand et al.
: Safety and quality of life analyses of apalutamide plus active surveillance vs active surveillance alone for low, intermediate risk prostate cancer. Genitourinary Cancers Symposium, Feb 2023, San Francisco, United States.
: DOI : https://doi.org/10.1200/JCO.2023.41.6_suppl.352

: 524 -
: Comparison of generic and specific anxiety in patients treated with apalutamide plus active surveillance vs active surveillance alone for low and intermediate risk prostate cancer.
: Gwenaelle Gravis, Rajae Touzani, Jochen Walz, Guillaume Ploussard, Pierre-Henri Savoie et al.
: Comparison of generic and specific anxiety in patients treated with apalutamide plus active surveillance vs active surveillance alone for low and intermediate risk prostate cancer. 2023 ASCO Annual Meeting, Jun 2023, Chicago, United States.
: DOI : https://doi.org/10.1200/JCO.2023.41.16_suppl.e17093

: 525 -
: IA et données de santé : regards croisés sur les droits, devoirs et responsabilités des personnes publiques
: Thomas Guyet, Pierre Saurel, Hélène Muscat, Christine Paillard, Tristan Allard et al.
: Enjeux scientifiques et sociaux de l’IA, MITI/CNRS, Jan 2023, Paris, France.

: 526 -
: O-179 Development of a European job exposure matrix (EuroJEM) for physical workload within exposome project for health and occupational research (EPHOR)
: Katarina Kjellberg, Ingrid Sivesind Mehlum, Eira Viikari-Juntura, Karina Undem, Alexis Descatha et al.
: 29th International Symposium on Epidemiology in Occupational Health (EPICOH 2023), Mar 2023, Mumbai, India.
: DOI : https://doi.org/10.1136/oem-2023-epicoh.159

: 527 -
: #4642 Do women have less access to the kidney transplantation waiting list than men in France?
: Latame Komla Adoli, Valerie Chatelet Pouliquen, Éric Daugas, Thierry Lobbedez, Elsa Vabret et al.
: 60th ERA Congress, Jun 2023, Milan, Italy.
: DOI : https://doi.org/10.1093/ndt/gfad063c_4642

: 528 -
: P08-11: Characterisation of the effects of Ketoconazole on the human fetal adrenal
: L. L. Lecante, P. Vazakidou, P. Lelandais, P. Liu, M. van Duursen et al.
: 57th Congress of the European Societies of Toxicology (EUROTOX 2023): TOXICOLOGY - MULTIDISCIPLINARY SCIENCE LEADING TO SAFER AND SUSTAINABLE LIFE, Sep 2023, Ljubljana, Slovenia. pp.S125-S126,
: DOI : https://doi.org/10.1016/s0378-4274(23)00561-1

: 529 -
: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS WITH LYSOZYME NEPHROPATHY AND CMML RENAL
: Marie-Camille Lafargue, Jean-Paul Duong-Van-Huyen, Pierre Isnard, Helmut Rennke, Marie Essig et al.
: 60th ERA Congress, Jun 2023, Milan, Italy.
: DOI : https://doi.org/10.1093/ndt/gfad063c_2664

: 530 -
: KIDNEY INVOLVEMENT INMYELODYSPLASTIC SYNDROMES
: Marie-Camille Lafargue, Jean-Paul Duong-Van-Huyen, Pierre Isnard, Helmut Rennke, Marie Essig et al.
: 60th ERA Congress, Jun 2023, Milan, Italy.
: DOI : https://doi.org/10.1093/ndt/gfad063c_2663